Format

Send to

Choose Destination
Br J Cancer. 2011 Mar 29;104(7):1057-8. doi: 10.1038/bjc.2011.79.

Current misconception 3: that subgroup-specific trial mortality results often provide a good basis for individualising patient care.

Abstract

Misconceptions and ill-founded theories can arise in all areas of science. However, the apparent accessibility of many epidemiology findings and popular interest in the subject can lead to additional misunderstandings. The article below is the third in an occasional series of short editorials highlighting some current misinterpretations of epidemiological findings. Invited authors will be given wide scope in judging the prevalence of the misconception under discussion. We hope that this series will prove instructive to cancer researchers in other disciplines as well as to students of epidemiology. Adrian L Harris and Leo Kinlen.

PMID:
21448174
PMCID:
PMC3068511
DOI:
10.1038/bjc.2011.79
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center